No. 21 CFR 211.113(a) calls for appropriate created methods being established and followed all through manufacturing to avoid objectionable microorganisms in drug items not needed to be sterile.   Furthermore, the second paragraph of USP Normal Chapter Antimicrobial Efficiency Screening reads:   A… Read More